Wen, Y., Hou, Y., Yi, X., Sun, S., Guo, J., He, X., . . . Wang, Z. (2021). EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells. Theranostics.
Chicago Style aipamenaWen, Yiping, Yaya Hou, Xiaoqing Yi, Si Sun, Jing Guo, Xiaoqi He, Tao Li, Jing Cai, and Zehua Wang. "EZH2 Activates CHK1 Signaling to Promote Ovarian Cancer Chemoresistance By Maintaining the Properties of Cancer Stem Cells." Theranostics 2021.
MLA aipamenaWen, Yiping, et al. "EZH2 Activates CHK1 Signaling to Promote Ovarian Cancer Chemoresistance By Maintaining the Properties of Cancer Stem Cells." Theranostics 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.